Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jss.2013.04.067 | DOI Listing |
J Surg Res
January 2014
Department of Surgery, Hofstra University School of Medicine, Old Bethpage, New York. Electronic address:
J Surg Res
August 2013
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuchang, Wuhan, PR China.
Background: It has been reported that the induction of heme oxygenase-1 (HO-1) mediated by β1-adrenergic receptor inhibits high mobility group box 1 protein (HMGB1) release and increases the survival rate in cecal ligation and puncture-induced septic mice. The present study aimed to investigate whether dobutamine, a selective β1-adrenergic receptor agonist, could inhibit HMGB1 release via β1-adrenergic receptor-mediated HO-1 induction and attenuate myocardial ischemia/reperfusion (I/R) injury in rats.
Materials And Methods: Anesthetized male rats were pretreated with dobutamine (5 or 10 μg.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!